Paxlovid: A Comprehensive Review of Mechanism, Efficacy, Resistance, and Future Directions in COVID-19 Management
Abstract Paxlovid (nirmatrelvir/ritonavir) has emerged as a critical oral antiviral for the treatment of mild-to-moderate COVID-19, demonstrating significant efficacy in preventing disease progression, hospitalization, and death, particularly in high-risk individuals. This comprehensive review delves into […]
